Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

BACKGROUND: Prostate-specific membrane antigen (PSMA)-directed radioligand therapy (RLT) is a promising yet not curative approach in castration-resistant (CR) prostate cancer (PC). Rational combination therapies may improve treatment efficacy. Here, we explored the effect of androgen receptor blocka...

Descripción completa

Detalles Bibliográficos
Autores principales: Lückerath, Katharina, Wei, Liu, Fendler, Wolfgang P., Evans-Axelsson, Susan, Stuparu, Andreea D., Slavik, Roger, Mona, Christine E., Calais, Jeremie, Rettig, Matthew, Reiter, Robert E., Herrmann, Ken, Radu, Caius G., Czernin, Johannes, Eiber, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206308/
https://www.ncbi.nlm.nih.gov/pubmed/30374743
http://dx.doi.org/10.1186/s13550-018-0451-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206308/
https://www.ncbi.nlm.nih.gov/pubmed/30374743
http://dx.doi.org/10.1186/s13550-018-0451-z

Ejemplares similares